You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Menveo
Menveo is the brand name for a meningococcal conjugate vaccine used to protect against infection caused by certain types of Neisseria meningitidis, the bacteria responsible for meningococcal disease. This vaccine helps prevent serious illnesses like meningitis and septicemia by targeting serogroups A, C, W, and Y. It is typically recommended for adolescents, certain high-risk groups, and travelers to regions where meningococcal disease is common.
Rx. Enter your prescription
How would you like to get your prescription? Select an option
Pharmacy pickup
Select from 35,000 pharmacies
Free two-day delivery
Coming soon!
Find a pharmacy near you. Enter your ZIP code
Are you a member? Sign up or log in.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
How much Bitcoin can you earn with Menveo ?
The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.
See the value of your savings today
Today's Value
1 Bitcoin = $NaN
Bitcoin (BTC)
...
USD
$NaN
Adjust Bitcoin's potential value to see how much it could be worth
Potential Value
1 Bitcoin =
Bitcoin (BTC)
...
USD
$NaN
Frequently Asked Questions
How long does Menveo protect against meningococcal disease?
Menveo typically provides protection for several years. Adolescents should receive a booster dose at age 16 to maintain immunity during their highest risk period.
Can I get Menveo if I’m already vaccinated against meningococcal disease?
Yes, Menveo may be recommended as a booster for individuals who have previously been vaccinated, especially if they are at high risk for meningococcal disease or traveling to an area where the disease is common.
Is Menveo safe for infants?
Yes, Menveo is approved for use in children as young as 2 months old who are at increased risk for meningococcal disease.
What should I do if I experience side effects after receiving Menveo?
Common side effects such as soreness at the injection site or mild fever should subside on their own. However, if you experience a severe allergic reaction or other concerning symptoms, seek medical attention immediately.
Can Menveo be given with other vaccines?
Yes, Menveo can be administered alongside other vaccines, but your healthcare provider may recommend spacing certain vaccines to ensure the best immune response. Always consult with your doctor for the correct vaccination schedule.
Comprehensive Drug Guide
How Does Menveo Work?
Menveo works by stimulating the immune system to produce antibodies against the Neisseria meningitidis bacteria (specifically serogroups A, C, W, and Y). The vaccine contains inactivated bacterial components, which train the immune system to recognize and attack the meningococcal bacteria if exposed in the future, providing protection against infection.
Common Dosages
- Pre-filled syringes or vials for injection: typically a single dose for most patients, administered intramuscularly.
Typical Dosing
- For adolescents: A single dose is typically administered at ages 11 to 12, followed by a booster dose at age 16.
- For high-risk individuals: The dosing schedule may vary depending on the patient's age and risk factors, with additional doses given based on the risk of ongoing exposure to Neisseria meningitidis.
Typical Dosing
FDA Approved Indications
- Adolescents aged 11 to 12, with a booster dose at age 16
- Individuals 2 months and older at increased risk of meningococcal disease
- People traveling to or living in areas where meningococcal disease is common, such as the "meningitis belt" in sub-Saharan Africa
Who Shouldn't Take Menveo?
- Known hypersensitivity or severe allergic reaction to any component of the vaccine
- History of severe allergic reaction to a previous dose of Menveo or any meningococcal vaccine
Advice From The Pharmacist
- Menveo is given as an injection by a healthcare provider, usually into the upper arm muscle.
- If you or your child have a weakened immune system, discuss with your healthcare provider if Menveo is the right vaccine for you.
- It’s essential to complete the full vaccination schedule, especially if you're traveling to a high-risk area.
- As with any vaccine, Menveo may not provide 100% protection, so it's crucial to maintain other preventive measures if you're at high risk of exposure to meningococcal bacteria.
Side Effects of Menveo
Common Side Effects
- Pain, redness, or swelling at the injection site
- Headache
- Fatigue or tiredness
- Muscle pain
Uncommon/Severe Side Effects
- Severe allergic reactions (anaphylaxis)
- High fever
- Seizures (rarely)
Risks and Warnings of Menveo
- Allergic Reactions: Severe allergic reactions can occur, although they are rare. If you experience symptoms such as hives, swelling of the face or throat, or difficulty breathing, seek immediate medical attention.
- Syncope (Fainting): Fainting after vaccination is possible, particularly in adolescents. It is recommended to sit or lie down for 15 minutes after receiving the injection to reduce this risk.
- Fever: Some people may develop a fever after receiving the vaccine. It is typically mild and resolves on its own but can be managed with over-the-counter medications if needed.
Interactions with Menveo
Common Drug Interactions
- Live vaccines: If you are receiving other vaccines, especially live vaccines, discuss with your healthcare provider as certain vaccines may need to be spaced out to avoid interactions.
- Immune-suppressing medications: Patients on immunosuppressive drugs may not have a full response to the vaccine. Discuss your medication regimen with your doctor before receiving Menveo.
Alternatives to Menveo
- Menactra: Another meningococcal conjugate vaccine targeting the same serogroups (A, C, W, and Y) as Menveo.
- Bexsero: A vaccine used to protect against Neisseria meningitidis serogroup B.
- Trumenba: Another option for preventing Neisseria meningitidis serogroup B.
- Meningococcal polysaccharide vaccines: Used in some regions, these provide protection against similar serogroups but are less commonly used than conjugate vaccines like Menveo.
